Financial Performance - Revenue for the three months ended June 30, 2023, was CAD 81,576,000, a 42.1% increase from CAD 57,455,000 in the same period of 2022[7] - Net revenue for the same period was CAD 75,110,000, up 49.9% from CAD 50,116,000 year-over-year[7] - Gross profit for the quarter was CAD 25,035,000, compared to CAD 7,130,000 in the prior year, reflecting a significant improvement[7] - The company reported a net loss of CAD 28,331,000 for the three months ended June 30, 2023, a decrease from a net loss of CAD 618,776,000 in the same quarter of 2022[10] - The net loss from continuing operations for the three months ended June 30, 2023, was $22,204,000, a significant improvement compared to a loss of $617,021,000 in the same period of 2022[17] - The company reported a total comprehensive loss of $26,898,000 for the period ending June 30, 2023[13] - The net loss attributable to Aurora shareholders for the three months ended June 30, 2023, was $26.9 million, compared to a loss of $618.8 million in the same period of 2022[75] - The company reported a net loss before taxes and discontinued operations of $22.108 million for the three months ended June 30, 2023, compared to a net loss of $618.384 million in the same period of 2022[86] Assets and Liabilities - Total assets decreased to CAD 832,188,000 as of June 30, 2023, down from CAD 926,322,000 at the end of March 2023[4] - Total liabilities were CAD 324,256,000 as of June 30, 2023, a reduction from CAD 409,185,000 at the end of the previous quarter[4] - Cash and cash equivalents decreased to CAD 157,855,000 from CAD 234,942,000 in the previous quarter[4] - The company’s total liabilities included accounts payable and accrued liabilities of $62.482 million as of June 30, 2023[90] - Non-current assets, excluding financial instruments, totaled $402.021 million as of June 30, 2023, compared to $417.150 million as of March 31, 2023[86] Cash Flow and Liquidity - The net cash used in operating activities for the three months ended June 30, 2023, was $11,237,000, an improvement from $26,642,000 in the same period of 2022[17] - The company has $1.5 million in future capital commitments due over the next 12 months[82] - The company’s cash and cash equivalents amounted to $157.855 million as of June 30, 2023[90] - The company believes its current liquidity position and access to the 2023 Shelf Prospectus are adequate to fund operating activities for the foreseeable future[98] - The company's primary short-term liquidity needs include funding net operating losses and lease payments[98] Inventory and Production - The total inventory as of June 30, 2023, was $103.008 million, a decrease from $106.132 million as of March 31, 2023, reflecting a 2.0% decline[36] - During the three months ended June 30, 2023, the inventory expensed to cost of goods sold was $64.4 million, down from $67.6 million in the same period of 2022[36] - The company produced 9,585 kilograms of dried cannabis, down from 16,109 kilograms in the same period of 2022[32] - The average selling price per gram of dried cannabis was CAD 5.05 as of June 30, 2023, with a potential impact of CAD 3,738 thousand on fair value for a CAD 1.00 change[32] - The weighted average yield per plant was 57.18 grams, with a sensitivity impact of CAD 1,247 thousand for a 5-gram change[32] Shareholder Information - The company issued 366,542,893 Common Shares as of June 30, 2023, an increase from 345,269,310 shares on March 31, 2023[56] - The weighted average number of common shares outstanding increased to 353,558,623 in Q2 2023 from 249,046,668 in Q2 2022[75] - The average exercise price of outstanding warrants decreased from CAD 7.09 to CAD 6.89 between March 31, 2023, and June 30, 2023[57] Expenses and Cost Management - The company incurred general and administrative expenses of CAD 21,874,000, down from CAD 30,139,000 in the same quarter of 2022[7] - Depreciation expense for the three months ended June 30, 2023, was $9.8 million, down from $14.5 million in the same period of 2022[39] - Share-based compensation for the three months ended June 30, 2023, amounted to $2,281,000, down from $3,472,000 in the same period of 2022[17] Future Outlook - The company’s future outlook includes continued focus on market expansion and product development to drive revenue growth[6] - The company has access to a 2023 Shelf Prospectus covering US$650.0 million of issuable securities, with approximately US$241 million available for potential new issuances[98]

Aurora Cannabis Inc. (NASDAQ:ACB) Q3 2023 Earnings Call Transcript June 14, 2023 8:15 AM ET Company Participants Ananth Krishnan - Vice President, Corporate Development and Strategy Miguel Martin - Chief Executive Officer & Director Glen Ibbott - Chief Financial Officer Conference Call Participants Michael Lavery - Piper Sandler Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Robin Holby - TD Cowen Tamy Chen - BMO Capital Markets John Zamparo - CIBC Operator Greetings. Welcome to th ...

Exhibit 99.1 Aurora Repurchases ~$47 Million Principal Amount of Convertible Notes, Saving $2.6 Million in Annualized Interest Payments; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry NASDAQ | TSX: ACB EDMONTON, AB, March 30, 2023 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $46.6 million (US$34.3 million) principal amount of its ...